NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

When untreated, this injury ... chronic UCL injuries. Our primary purpose was to compare nonoperative treatment with surgical repair and surgical reconstruction of thumb UCL injuries. A secondary ...

In bad news, there are a couple recent concerns in the secondary in Rasul Douglas and Taylor ... Alim McNeill R jaw injury videos -Suspicion for chronic TMJ. Nerve pain, other things also possible.

ed.ac.uk Myocardial injury ... primary and secondary endpoints,2–4 it has not been widely adopted in clinical practice, and the frequency and implications of subtypes of acute myocardial infarction ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the ...

The study, which followed four patients with chronic spinal cord injuries for five years, found that two patients showed durable evidence of neurological improvement after treatment with neural ...

A phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

The study, which followed four patients with chronic spinal cord injuries for five years, found that two patients showed durable evidence of neurological improvement after treatment with neural ...